INTRODUCTIONCase Synopsis: A 10-year-old female with a history of Crohn’s disease (CD) presented with a rash on her scalp and trunk and associated hair loss for several months. She had…
Read More
INTRODUCTIONOrgan transplant recipients (OTRs) are at increased risk for skin cancer, especially non-melanoma skin cancer (NMSC). In OTRs, NMSC tends to be more aggressive and result in higher rates of…
Read More
INTRODUCTIONRosacea is a chronic, inflammatory dermatosis primarily affecting the central face that affects approximately 10% of adults,1,2 with higher rates in women and those with Fitzpatrick skin Types I to…
Read More
INTRODUCTIONSkin cancer is currently the most common type of cancer worldwide as it affects more than 3 million Americans annually.1 When feasible, many head and neck non-melanoma skin cancers (NMSC;…
Read More
INTRODUCTIONTopical retinoids remain the mainstay of therapy for acne vulgaris.1 They are, however, associated with skin irritation during the initial weeks of application. Erythema, scaling, dryness, burning, and pruritis of…
Read More
ARTICLESIn this supplement, featured articles include:Game Changer in Acne TreatmentAn introduction to this month's supplement on Androgens. Of the four primary pathogenic factors that drive acne vulgaris—androgen excess, increased sebum…
Read More
Of the four primary pathogenic factors that drive acne vulgaris—androgen excess, increased sebum production, faulty keratinization, and overgrowth of C. acnes—androgen excess has been the most elusive therapeutic target. Oral…
Read More
INTRODUCTIONThe major steroid sex hormones, androgens and estrogens, play vital roles in maintaining gender characteristics, normal activities of reproductive organs, and other physiologic functions in different organ systems, including skin.…
Read More
INTRODUCTIONAging is a natural result of gradual anatomical changes in all facial layers. The most dramatic alterations occur in subcutaneous fatty layer.1 In the normal individual, fat deposition in specific…
Read More
Pediatric periorificial dermatitis (POD) is a papulopustular facial eruption that can be exacerbated by topical steroid use.1 Crisaborole (Eucrisa®) is a relatively new steroid-sparing topical agent approved for treatment of…
Read More
INTRODUCTIONIn recent years, The National Psoriasis Foundation has emphasized the importance of achieving skin clearance targets during the course of treatment.1 However, many patients with psoriasis stop and restart treatment…
Read More
INTRODUCTIONAs the facial aging process includes changes in skin, bone structure, fat and muscle,1 a wide range of fillers, toxins and energy-based technologies have been developed to combat the aging…
Read More
